Elizabeth Holland > A&O Shearman > New York, United States > Lawyer Profile
A&O Shearman Offices
![A&O Shearman company logo](https://www.legal500.com/wp-content/uploads/sites/13/2024/05/AOShearman_Logo-300x26.jpg?v=1715761991)
1221 AVENUE OF THE AMERICAS
NEW YORK, NY 10020
NEW YORK
United States
- Firm Profile
- Go to...
Elizabeth Holland
![Elizabeth Holland photo](https://www.legal500.com/wp-content/uploads/sites/13/2024/05/Small-Holland_Elizabeth_3038341-300x225.jpg)
Work Department
IP Litigation
Position
Partner
Career
Elizabeth is Global Co-Head of IP Litigation at A&O Shearman.
She is a first-chair trial lawyer who focuses exclusively on representing innovators in patent infringement and related litigation in the life sciences space. With over 35 years of experience, Elizabeth has served as lead counsel in numerous patent infringement litigations, licensing disputes, arbitrations, IPR proceedings and Federal Circuit appeals. She has particular expertise in Hatch-Waxman and BPCIA litigation, as well as disputes between innovator companies.
Elizabeth is consistently ranked among the top lawyers in her field by publications such as Chambers Global, Chambers USA, IAM 1000 – The World’s Leading Patent Practitioners, The Legal 500 U.S., Managing Intellectual Property, LMG Life Sciences and Euromoney, which have noted her “assured handling of even the most complex pharmaceuticals patent cases” and have described her as “exactly what you want in a first-chair lawyer; she is very skilled in the courtroom, very adept at managing multiple important cases, and well-liked by judges.”
Elizabeth has also been noted as being “exceptional on her feet in court;” getting “excellent results;” and “understanding clients’ business goals and litigating with those in mind.” She has thrice been named “Hatch Waxman Litigator of the Year” by LMG Life Sciences and has been featured as a “Winning Litigator” by the National Law Journal.
Elizabeth has successfully represented companies such as Novartis, Takeda, Wyeth, Celltrion, Ceva Sante, Enzymotec, and Boston Scientific in patent litigation in district courts throughout the United States, at the International Trade Commission, in post-grant proceedings before the PTAB, and at the Federal Circuit. She has also coordinated worldwide patent litigation, and has particular experience with courts in the UK, Netherlands, France, Israel, India and Mexico.
At her previous firms, Elizabeth served on the Executive, Management, and Partnership committees and chaired the Diversity, Equity + Inclusion Committee.
Lawyer Rankings
United States > Intellectual property > Patents: litigation (full coverage)
Led by seasoned life sciences litigator Elizabeth Holland in New York, A&O Shearman is praised as ‘second to none‘ in its knowledge of patent litigation and is a key port of call for clients in the life sciences, tech, semiconductor and consumer goods industries. The team is also noted for its expertise in breach of contract and trade secret disputes. Shamita Etienne-Cummings and Lisa Nguyen left the firm in March 2024.
Lawyer Rankings
Top Tier Firm Rankings
Firm Rankings
- Finance > Capital markets: debt offerings
- Antitrust > Civil litigation/class actions: defense
- Environment > Environment: transactional
- Tax > Financial products
- Dispute resolution > Financial services litigation
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- Finance > Project finance
- Energy > Renewable/alternative power
- Finance > Structured finance: derivatives and structured products
- Finance > Structured finance: securitization
- Tax > US taxes: non-contentious
- Finance > Capital markets: equity offerings
- Finance > Capital markets: high-yield debt offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Antitrust > Merger control
- Media, technology and telecoms > Outsourcing
- Media, technology and telecoms > Technology transactions
- Finance > Capital markets: global offerings
- Antitrust > Cartel
- Energy > Energy regulation: electric power
- Energy > Energy transactions: oil and gas
- Finance > Fintech
- Real estate > Real estate finance
- Finance > Financial services regulation
- Dispute resolution > International arbitration
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: contentious
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: litigation (International Trade Commission)
- Media, technology and telecoms > Advertising and marketing: litigation